Related Experiment Videos
Congenital astroblastoma: an immunohistochemical study. Case report
1Imperial Cancer Research Fund, Paediatric and Neuro-Oncology Laboratory, Frenchay Hospital, Bristol, United Kingdom.
Journal of Neurosurgery
|September 1, 1995
Summary
This study details the second congenital astroblastoma case, a rare glial tumor. The infant showed a positive response to chemotherapy, remaining alive and well for 2.5 years post-diagnosis.
Area of Science:
- Neuro-oncology
- Pediatric oncology
- Rare tumors
Background:
- Astroblastoma is a rare glial tumor typically affecting older children and young adults.
- Characterized by a unique histological pattern of radiating cells forming perivascular pseudorosettes.
Observation:
- Presents the second reported case of congenital astroblastoma, an extremely rare presentation.
- The infant underwent subtotal tumor resection followed by chemotherapy.
Findings:
- The infant received 10 cycles of vincristine, etoposide, and carboplatinum chemotherapy.
- Demonstrated evidence of tumor response to chemotherapy, a novel observation for this condition.
- The child remains alive 2.5 years post-diagnosis with good functional status.
Implications:
- Suggests chemotherapy may be an effective treatment modality for congenital astroblastoma.
- Highlights the importance of considering rare tumor types in congenital central nervous system malignancies.
- Provides insights into the biology, natural history, and management of this rare neoplasm.